查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866525

全球微生物附着量检测市场－2025-2030年预测

Global Bioburden Testing Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

微生物附着量检测市场预计将从 2025 年的 17.73 亿美元成长到 2030 年的 34.53 亿美元，复合年增长率为 14.27%。

微生物附着量测试，也称为微生物计数 (MET)，用于量化医疗设备和药品上的活微生物数量，​​从而确保产品安全。此测试透过测量微生物数量来确定医疗设备的最佳灭菌参数，这是确保符合严格监管标准的关键步骤。

受製药和医疗设备产业持续扩张以及监管要求日益严格的推动，微生物附着量检测市场预计将迎来显着成长。然而，检测设备的高成本和冗长的核准流程可能会在预测期内阻碍市场扩张。

本研究检验了目前微生物附着量市场发展的最新动态。研究全面分析了关键驱动因素、限制因素和机会，并深入剖析了不同地区的行业趋势、政策和法规，使相关人员能够深入了解法律规范和影响市场环境的因素。

我们的竞争情报是基于广泛的二手资料研究，旨在识别关键产业参与者及其收入贡献。资讯来源包括产业协会调查、分析师报告、投资者报告、新闻稿和学术期刊。我们采用自下而上和自上而下的方法计算了微生物附着量检测市场及其主要细分市场的整体市场规模。相关数据已透过全球微生物附着量检测价值链相关人员的第一手资讯进行检验。我们全面的市场分析整合了多种资讯来源和专有资料集，并运用资料三角验证法，以提供准确的市场区隔和预测。

报告透过分析说明、图表和图形呈现市场洞察，以便有效了解全球微生物附着量检测市场的动态。主要企业简介包括SGS SA、赛默飞世尔科技和贝克顿·迪金森公司。

本报告为业内专业人士提供关于市场趋势、法规环境和竞争动态的关键洞察。报告重点阐述了产业扩张和合规需求带来的成长机会，同时也探讨了高成本和冗长的核准流程等挑战。严谨的调查方法，结合一手和二手数据，确保了报告内容的可靠性。本报告能够帮助相关人员应对监管的复杂性、竞争压力和投资重点，从而保障医疗器材和药品的安全性和有效性。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 全球微生物附着量检测市场（依产品划分）

  • 介绍
  • 消耗品
    • 培养基
    • 试剂盒和试剂
    • 其他的
  • 装置
    • PCR装置
    • 显微镜
    • 流式细胞仪
    • 自动微生物鑑定係统
  • 软体和服务

6. 全球微生物附着量检测市场（依应用划分）

  • 介绍
  • 原料测试
  • 医疗设备测试
  • 进程内测试
  • 环境监测

7. 全球微生物附着量检测市场（依最终用户划分）

  • 介绍
  • 製药和生物技术製造商
  • CMO（委外研发机构）
  • 医疗设备製造商
  • 其他的

8. 全球微生物附着量检测市场（按地区划分）

  • 介绍
  • 北美洲
    • 副产品
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 副产品
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 副产品
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 义大利
      • 其他的
  • 中东和非洲
    • 副产品
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 副产品
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Merck KGaA
  • Pacific BioLabs Inc.
  • Mettler Toledo International Inc.
  • Charles River Laboratories, Inc.
  • Rapid Micro Biosystems, Inc.
  • Thermo Fisher Scientific
  • WuXi AppTec
  • Becton, Dickinson, and Company
  • SGS SA
  • Nelson Laboratories, LLC
  • bioMerieuxx SA

第十一章 分析方法

简介目录
Product Code: KSI061611930

The Bioburden Testing Market is expected to soar from USD 1.773 billion in 2025 to USD 3.453 billion in 2030, at a CAGR of 14.27%.

Bioburden testing, also known as microbial enumeration testing (MET), quantifies viable microorganisms on medical devices or pharmaceutical ingredients, ensuring product safety for manufacturers. This testing determines microbial counts to establish optimal sterilization parameters for medical devices, a critical step in maintaining compliance with stringent regulatory standards.

The bioburden testing market is poised for significant growth, driven by the expanding pharmaceutical and medical device industries and rigorous regulatory requirements. However, high costs of testing instruments and prolonged approval processes may impede market expansion during the forecast period.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the bioburden testing market. It provides a comprehensive analysis of key drivers, restraints, and opportunities. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a thorough understanding of the regulatory framework and factors influencing the market environment.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall bioburden testing sector and its key segments was determined using both bottom-up and top-down methodologies. Values were validated with primary inputs from stakeholders in the global bioburden testing value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling efficient comprehension of global bioburden testing market dynamics. Key players profiled include SGS SA, Thermo Fisher Scientific, and Becton, Dickinson, and Company, among others.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights growth opportunities driven by industry expansion and compliance needs while addressing challenges such as high instrument costs and lengthy approval timelines. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate regulatory complexities, competitive pressures, and investment priorities in a market vital to ensuring the safety and efficacy of medical devices and pharmaceuticals.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Products

  • Consumables
  • Culture Media
  • Kits and Reagents
  • Others
  • Instruments
  • PCR Equipment
  • Microscopes
  • Flow cytometers
  • Automated microbial identification systems
  • Software & Services

By Application

  • Raw Material Testing
  • Medical Devices Testing
  • In-Process Testing
  • Environmental Monitoring

By End-User

  • Pharmaceuticals and Biotechnology Manufacturers
  • CMOs
  • Medical Device Manufacturers
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BIOBURDEN TESTING MARKET BY PRODUCTS

  • 5.1. Introduction
  • 5.2. Consumables
    • 5.2.1. Culture Media
    • 5.2.2. Kits and Reagents
    • 5.2.3. Others
  • 5.3. Instruments
    • 5.3.1. PCR Equipment
    • 5.3.2. Microscopes
    • 5.3.3. Flow cytometers
    • 5.3.4. Automated microbial identification systems
  • 5.4. Software & Services

6. BIOBURDEN TESTING MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Raw Material Testing
  • 6.3. Medical Devices Testing
  • 6.4. In-Process Testing
  • 6.5. Environmental Monitoring

7. BIOBURDEN TESTING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Pharmaceuticals and Biotechnology Manufacturers
  • 7.3. CMOs
  • 7.4. Medical Device Manufacturers
  • 7.5. Others

8. BIOBURDEN TESTING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Products
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Products
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Products
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Others
  • 8.5. Middle East & Africa
    • 8.5.1. By Products
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Products
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Merck KGaA
  • 10.2. Pacific BioLabs Inc.
  • 10.3. Mettler Toledo International Inc.
  • 10.4. Charles River Laboratories, Inc.
  • 10.5. Rapid Micro Biosystems, Inc.
  • 10.6. Thermo Fisher Scientific
  • 10.7. WuXi AppTec
  • 10.8. Becton, Dickinson, and Company
  • 10.9. SGS SA
  • 10.10. Nelson Laboratories, LLC
  • 10.11. bioMerieuxx SA

11. RESEARCH METHODOLOGY